Insider Buying: Guided Therapeutics CEO Acquires 76,000 Shares of Stock (GTHP)
Guided Therapeutics (NASDAQ:GTHP) CEO Gene S. Cartwright purchased 76,000 shares of the company’s stock on the open market in a transaction dated Wednesday, June 18th. The stock was purchased at an average cost of $0.48 per share, with a total value of $36,480.00. Following the completion of the purchase, the chief executive officer now directly owns 2,050,000 shares in the company, valued at approximately $984,000. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Shares of Guided Therapeutics (NASDAQ:GTHP) traded up 1.23% during mid-day trading on Monday, hitting $0.495. 114,490 shares of the company’s stock traded hands. Guided Therapeutics has a 1-year low of $0.47 and a 1-year high of $0.98. The stock’s 50-day moving average is $0.68 and its 200-day moving average is $0.73. The company’s market cap is $35.7 million.
Guided Therapeutics, Inc is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.